Literature DB >> 17325152

Protective effect of uridine on cornea in a rabbit dry eye model.

Joo Youn Oh1, Youn Seok In, Mee Kum Kim, Jung Hwa Ko, Hyun Ju Lee, Ki Cheul Shin, Sang Mok Lee, Won Ryang Wee, Jin Hak Lee, Myunggyu Park.   

Abstract

PURPOSE: To investigate the effect of uridine on cultured human corneal epithelial cells and keratocytes in vitro and to evaluate whether the application of uridine-containing eye drops could improve ocular surface health in an in vivo dry eye model.
METHODS: Uridine was added to cultured epithelial cells (3 x 10(4) cells/well) and keratocytes (1 x 10(4) cells/well) at various concentrations (0.5-50 microM). Cytotoxicity was tested with the use of MTT assay, and the cells were assessed for apoptosis with the use of flow cytometry. Expressions of hyaluronic acid (HA), glycosaminoglycan (GAG), nitric oxide (NO), and matrix metalloproteinase (MMP)-9 were measured. In vivo, the degree of reepithelialization was assessed after topical application of uridine (100 microM) in a rabbit corneal wound model. Changes in tear production and conjunctival goblet cell counts were investigated after instillation of various concentrations of uridine-containing eye drops in a rabbit dry eye model.
RESULTS: In vitro, uridine showed no cellular toxicity. It increased the biosynthesis of HA and GAG and reduced MMP-9 levels in cultured corneal epithelial cells and keratocytes. In vivo, uridine enhanced corneal wound healing and significantly increased the number of conjunctival goblet cells in rabbits.
CONCLUSIONS: Uridine can restore the health of the ocular surface in a rabbit corneal wound and dry eye model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325152     DOI: 10.1167/iovs.06-0809

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Animal model with structural similarity to human corneal collagen fibrillar arrangement.

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; Logan Mitchell; George J Dias
Journal:  Anat Sci Int       Date:  2021-01-03       Impact factor: 1.741

Review 2.  Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.

Authors:  Marjan Farid; Anshu Agrawal; Daniel Fremgen; Jeremiah Tao; He Chuyi; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Ocul Immunol Inflamm       Date:  2014-12-23       Impact factor: 3.070

3.  Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.

Authors:  Sabrina Viau; Marie-Annick Maire; Bruno Pasquis; Stéphane Grégoire; Cynthia Fourgeux; Niyazi Acar; Lionel Bretillon; Catherine P Creuzot-Garcher; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-21       Impact factor: 3.117

4.  Pharmacokinetics of uridine following ocular, oral and intravenous administration in rabbits.

Authors:  Eunyoung Kim; Wonku Kang
Journal:  Biomol Ther (Seoul)       Date:  2013-03       Impact factor: 4.634

5.  Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis.

Authors:  Sudeep Chenna Narendra; Jaya Prakash Chalise; Mattias Magnusson; Srinivas Uppugunduri
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

6.  Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice.

Authors:  Manish Kumar Jeengar; Dinesh Thummuri; Mattias Magnusson; V G M Naidu; Srinivas Uppugunduri
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

7.  Astragalus Ⅳ ameliorates the dry eye injury in rabbit model <em>via</em> MUC1-ErbB1 pathway.

Authors:  Li Chu; Suhong Ma; Zhiwei Chen; Wenfu Cao
Journal:  Eur J Histochem       Date:  2021-04-01       Impact factor: 3.188

8.  Preliminary effects of oral uridine on the ocular surface in dry eye patients.

Authors:  Ki Cheol Chang; Joo Youn Oh; Youn Seok In; Mee Kum Kim; Ki Cheul Shin; Won Ryang Wee; Jin Hak Lee; Myung Gyu Park
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.